Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05190497
Other study ID # IMT in inhalation injury
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 30, 2021
Est. completion date February 28, 2022

Study information

Verified date December 2021
Source Cairo University
Contact KHALED T AHMED, Asso Prof
Phone 00201115586016
Email khaled.takey@must.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The current study aimed to investigate the effect of inspiratory muscle training (IMT) on pulmonary functions (FEV1and FVC), and respiratory muscle strength in patients with inhalation injury, which may prove to be a promising intervention helping to improve exercise tolerance, relieve dyspnea and suggests an improvement in respiratory muscle function.


Description:

Forty male patients suffering from inhalation injury were been included in this study, Participants' ages ranged from 20-35 years old. Patients were selected from the burn department, Om El-Masreen hospital, and randomly assigned into two equal groups. The exercise group received inspiratory muscle training in addition to routine chest physiotherapy in the form of (deep breathing, coughing, and early ambulation) three times per week for four weeks (group A). The Control group received only routine chest physiotherapy (group B). This study obtained ethical approval by the institutional review board of the Faculty of Physical Therapy - Cairo University, with reference number: P.T.REC/012/003431


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date February 28, 2022
Est. primary completion date February 15, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years to 35 Years
Eligibility Inclusion criteria: - Male patients suffering from inhalation injury. - Participant age ranged from 20-35 years old. - All patients had the same medical care. - Participants have received a good explanation of the treatment and measurement device. - Treatment was conducted one month after inhalation injury. Exclusion criteria: Patients were excluded from this study for any of the following cases such as - Instability of patient's medical condition. - Presence of any diseases that could affect the study results. - Participants having respiratory, cardiac, or neurological diseases that affect pulmonary functions.

Study Design


Intervention

Device:
Exercise group
Maximal respiratory pressure and reflecting muscles strength were measured by a mouth pressure meter

Locations

Country Name City State
Egypt Khaled Takey Ahmed Giza

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Gupta K, Mehrotra M, Kumar P, Gogia AR, Prasad A, Fisher JA. Smoke Inhalation Injury: Etiopathogenesis, Diagnosis, and Management. Indian J Crit Care Med. 2018 Mar;22(3):180-188. doi: 10.4103/ijccm.IJCCM_460_17. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary PULMONARY FUNCTION TEST Each patient's weight in kilograms, and height in meters were recorded and entered the machine. An individual sat in a chair and inhaled deeply before closing their mouth tightly around the tube. Several exercises were carried out until the patient comprehended and was comfortable with the instruction. The patient inhaled deeply and exhaled as quickly as possible into the spirometer(Morgan Trans Flow Test Vicatest p2 (Kent, ME 87 ED, England). 3 MONTHS
Primary Respiratory muscles Strength Measurement Maximal respiratory pressure and reflecting muscles strength were measured by a mouth pressure meter (Pony FX; COSMED, Rome, Italy) in the sitting position. The highest maximal expiratory pressure (MEP) in cmH2O, and maximal inspiratory pressure (MIP) in cmH2O values in three or more attempts were chosen. Investigators calculated the predicted MEP and MIP values based on age, height, and weight 3 MONTHS
See also
  Status Clinical Trial Phase
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT02239744 - Intervention Study on the Health Impact of Air Filters in Chinese Adults N/A
Completed NCT00795964 - Influence of Tidal Volume on Postoperative Pulmonary Function N/A
Completed NCT04880486 - Weight Training With VR in Out-Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Completed NCT03697174 - Acute Health Effects of Ozone Exposure N/A
Completed NCT02200289 - In Utero Household Air Pollution Exposure and Lung Development in Ghana N/A
Withdrawn NCT00749762 - Pulmonary Function During Prone and Supine Positioning in NICU Infants Requiring Assisted Ventilation N/A
Recruiting NCT06106646 - Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
Completed NCT04256070 - Effect of Education and Tele-consultancy Intervention Based on Watson Human Care Theory Individuals With COPD N/A
Completed NCT02151669 - Diet Intervention Spirometry and Tobacco N/A
Not yet recruiting NCT01719393 - Pulse Spectrum Analysis in Adult Asthmatics: Correlation With Lung Function, Asthma Control Exhaled Nitric Oxide and Metabolites in Exhaled Breath Condensate N/A
Completed NCT06073275 - Effects of Beetroot Juice Intake on Performance and Physiological Parameters N/A
Completed NCT03885583 - Post-operative Pulmonary Function After Kidney Surgery Under Two Different Techniques N/A
Completed NCT04734743 - Muscle Strength, Functional Capacity, Respiratory Function and Quality Of Life In Cystic Fibrosis Patients N/A
Enrolling by invitation NCT02825654 - Service and Health Among Deployed Veterans
Recruiting NCT03203603 - VCSIP Follow-up Study
Completed NCT05023876 - The Effect of Instrument Assisted Soft Tissue Mobilization on Respiratory Functions in Chronic Obstructive Pulmonary Disease N/A
Recruiting NCT03206710 - Vitamin C Supplementation to Pregnant Smokers: Follow-up of 2 Randomized Trials Plus Changes in DNA Methylation
Completed NCT03167918 - Lung Function in Patients With Early Type 2 Diabetes Mellitus Phase 2/Phase 3
Active, not recruiting NCT01728571 - LungVITamin D and OmegA-3 Trial (lungVITAL) N/A